Latitude Advisors’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$514K Sell
2,312
-1
-0% -$233 0.16% 132
2026
Q2
$549K Sell
2,313
-487
-17% -$101K 0.22% 112
2026
Q1
$592K Buy
2,800
+69
+3% +$14.9K 0.27% 94
2025
Q4
$561K Buy
2,731
+133
+5% +$25K 0.25% 94
2025
Q3
$408K Buy
2,598
+53
+2% +$8.19K 0.19% 113
2025
Q2
$428K Hold
2,545
– – 0.22% 106
2025
Q1
$351K Buy
2,545
+128
+5% +$16.3K 0.2% 118
2024
Q4
$286K Sell
2,417
-313
-11% -$36.5K 0.16% 138
2024
Q3
$302K Hold
2,730
– – 0.17% 131
2024
Q2
$268K Buy
2,730
+206
+8% +$21K 0.16% 133
2024
Q1
$282K Buy
2,524
+12
+0.5% +$1.3K 0.18% 120
2023
Q4
$253K Buy
2,512
+146
+6% +$14.5K 0.18% 134
2023
Q3
$205K Hold
2,366
– – 0.15% 154
2023
Q2
$224K Buy
+2,366
New +$200K 0.16% 139

Other funds holding CAH

Latitude Advisors's CAH Position: Q3 2026 in Review

Latitude Advisors reduced its Cardinal Health (CAH) stake by 0.04% in Q3 2026, selling an estimated $233 and leaving 2,312 shares worth $514K. The position accounts for 0.16% of the portfolio, ranked #132.

Latitude Advisors first reported a position in CAH in Q2 2023 and has held it in 14 quarters since. The position peaked at $592K in Q1 2026. 1,495 funds tracked by Wall St. Rank hold CAH as of Q3 2026.

  • Latitude Advisors held 2,312 shares of Cardinal Health worth $514K as of Q3 2026.
  • Latitude Advisors sold 1 Cardinal Health share in Q3 2026, an estimated $233.
  • Cardinal Health made up 0.16% of Latitude Advisors's portfolio in Q3 2026, its #132 holding.
  • Latitude Advisors first reported a position in Cardinal Health in Q2 2023 and has held it in 14 quarters since.
  • Latitude Advisors's Cardinal Health position peaked at $592K in Q1 2026.
  • 1,495 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2026.

Based on Latitude Advisors's 13F filing for Q3 2026, filed 27 Oct 2026.